The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3275867
WO Application Number:
CN2016073043
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16767632.9
WO Publication Number:
WO2016150255
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
China (CN)
Publications:
Dates
Filing date:
01/02/2016
Grant date:
10/06/2020
EP Publication Date:
31/01/2018
WO Publication Date:
29/09/2016
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
10/06/2020
EP B1 Publication Date:
10/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
31/01/2036
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
10/06/2020
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
10/06/2020
Name:
Shanghai Yingli Pharmaceutical Co. Ltd.
Address:
Room 311, Building 6
576 Libing Road
Zhangjiang High-Tech Park
Pudong New Area, Shanghai 201203, China (CN)